A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population

Status:
Withdrawn

Trial end date:
2007-10-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the blood levels and the tolerability of SB-649868 in Elderly and Female population

Phase 1

GlaxoSmithKline